Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | HTR1A | P08908 | 2/20 | 0.49 |
| ▸ | DRD2 | P14416 | 3/20 | 0.47 |
| ▸ | DRD3 | P35462 | 3/20 | 0.47 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HTR2C | P28335 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7025590 | 1.00 | KDM4E (0.51) | KDM4ELMNAHTR1ADRD2DRD3 | |
| SCHEMBL7029875 | 0.99 | KDM4E (0.53) | KDM4ELMNAHTR1ADRD2DRD3 | |
| SCHEMBL7029878 | 0.99 | KDM4E (0.53) | KDM4ELMNAHTR1ADRD2DRD3 | |
| SCHEMBL7021575 | 0.96 | DRD2 (0.51) | KDM4ELMNAHTR1ADRD2DRD3 | |
| SCHEMBL7021581 | 0.96 | DRD2 (0.51) | KDM4ELMNAHTR1ADRD2DRD3 | |
| SCHEMBL7027637 | 0.91 | DRD2 (0.49) | DRD2DRD3DPP4 | |
| SCHEMBL7027642 | 0.91 | DRD2 (0.49) | DRD2DRD3DPP4 | |
| SCHEMBL6816574 | 0.83 | DRD3 (0.47) | DRD2DRD3 | |
| SCHEMBL4788557 | 0.83 | DRD3 (0.47) | DRD2DRD3 | |
| SCHEMBL7025288 | 0.83 | DRD3 (0.47) | DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0888319-B1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | ASTRAZENECA AB (SE) | 2003-01-29 | — | — | EP | disclosed |
| US-6410530-B1 | CENTRAL NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS | ASTRAZENECA AB (SE) | 2002-06-25 | — | — | US | disclosed |
| US-6124283-A | Substituted 1,2,3,4-tetrahydronaphthalene derivatives | ASTRA AKTIEBOLAG (SE) | 2000-09-26 | — | — | US | disclosed |
| EP-0888319-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | Astra Aktiebolag (SE) | 1999-01-07 | — | — | EP | disclosed |
| WO-1997034883-A1 | SUBSTITUTED 1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | ASTRA AKTIEBOLAG (SE) | 1997-09-25 | — | — | WO | disclosed |